On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Study Supports Injected Methylcobalamin for Subacute Herpetic Neuralgia Treatment
Results of a recent clinical trial by researchers at the Department of Rehabilitation Medicine in the Affiliated Tenth People's Hospital of Tongji University, in Shanghai, China, have deemed locally injected methylcobalamin more effective than its orally administered counterpart as a treatment for subacute herpetic neuralgia.
Miscommunication is a frequently cited cause of preventable medical error, A new study finds that ambient background noise, whether it is loud equipment, talk among team members, or music, is a patient and surgical safety factor that can affect auditory processing among surgeons and surgical team members in the operating room (OR).
Copper Surfaces Reduce ICU Infections by 60 Percent
Researchers at the Medical University of South Carolina (MUSC) have published a study in Infection Control and Hospital Epidemiology's May 2013 issue showing that copper surfaces in intensive care unit (ICU) rooms reduced health-acquired infections (HAIs) by 60 percent.
Pulse Oximetry Neonatal Screening Can Save Lives at Low Cost
A statewide neonatal screening program in New Jersey designed to detect critical congenital heart defects (CCHDs) using pulse oximetry has been shown to save lives while putting little burden on hospital staff, according to a report from the US Centers for Disease Control and Prevention (CDC).
Medicare Proposes to Increase Payments to US Acute Care Hospitals
The Centers for Medicare and Medicaid Services (CMS) has issued a proposed rule, published in the Federal Register on May 10, 2013, to increase payments to US acute care hospitals by almost $27 million in fiscal year 2014.
Identifying Symptoms of Irritable Bowel Syndrome in Patients with Inflammatory Bowel Disease
May 15th 2013Patients who have IBD, even those who are in clinical remission, often exhibit symptoms consistent with IBS, which can complicate the assessment and management of IBD and lead to unnecessary interventions.
Researchers Measure Complex Migraine Aura Duration, Recommend Disorder Category Change
Though the third edition of the International Classification of Headache Disorders (ICHD-III) proposes to label aura in non-hemiplegic migraine that lasts longer than one hour but shorter than one week as probable migraine with aura - or probable complex migraine - a group of researchers from Italy, Switzerland, Germany, and California decided to analyze clinical studies to determine whether or not that timeframe aligns with the typical duration of migraine aura.
Tolvaptan Therapy Produces Good Outcomes in Patients with Heart Failure and Hyponatremia
May 3rd 2013Results from a small retrospective study indicate that treatment with tolvaptan increases sodium concentrations and excretion rhythm without significantly affecting kidney function in patients with refractory hyponatremia and dcompensated heart failure.
FDA Limits Usage, Duration of Hyponatremia Drug Due to Observed Liver Damage Risk
Citing an increased risk of liver injury observed in recent clinical trials, the US Food and Drug Administration (FDA) has limited Samsca (tolvaptan) treatment to 30 days and recommended the oral selective vasopressin V2-receptor antagonist be discontinued in patients with signs of liver disease or symptoms of liver injury.
FDA Approves Kcentra to Reverse Warfarin-Induced Anticoagulation
The US Food and Drug Administration (FDA) today approved Kcentra [prothrombin complex concentrate (human)] for the urgent reversal of anticoagulation induced by vitamin K antagonist (VKA) therapies such as warfarin in adult patients with acute major bleeding.
New Diabetes Management Guidelines Consider Concurrent Conditions
In diagnosing a patient with type 2 diabetes, an endocrinologist or primary care physician may struggle with developing healthy treatment targets when comorbid conditions like obesity and hypoglycemia are at play.